Fig. 5
From: Biological and pharmacological roles of m6A modifications in cancer drug resistance
m6A-induced specific drug resistance. Specific chemotherapy drug resistance associated with m6A and related regulators in esophageal squamous cell carcinoma (ESCC), lung adenocarcinoma (LUAD), intrahepatic cholangiocarcinoma (ICC), glioblastoma multiforme (GBM), breast cancer (BC), clear cell renal cell carcinoma (ccRCC)